ANTH

Anthera Pharmaceuticals, Inc.
ANTH

Delisted

ANTH was delisted on the 27th of June, 2018.

28 hedge funds and large institutions have $621K invested in Anthera Pharmaceuticals, Inc. in 2018 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 8 increasing their positions, 6 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
28
Holders Change
-9
Holders Change %
-24.32%
% of All Funds
0.64%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
7
Increased
8
Reduced
6
Closed
16
Calls
$452K
Puts
$14K
Net Calls
+$438K
Net Calls Change
-$436K
Name Holding Trade Value Shares
Change
Shares
Change %
6CM
26
683 Capital Management
New York
-$399K -276,809 Closed
Millennium Management
27
Millennium Management
New York
-$111K -67,339 Closed
ARTA
28
A.R.T. Advisors
New York
-$58K -35,300 Closed
Neuberger Berman Group
29
Neuberger Berman Group
New York
-$56K -34,110 Closed
D.E. Shaw & Co
30
D.E. Shaw & Co
New York
-$41K -24,606 Closed
OAM
31
Oxford Asset Management
United Kingdom
-$32K -20,133 Closed
BC
32
Birchview Capital
Vermont
-$23K -15,378 Closed
DADC
33
D.A. Davidson & Co
Montana
-$23K -13,958 Closed
Macquarie Group
34
Macquarie Group
Australia
-$9K -5,500 Closed
CHP
35
Cable Hill Partners
Oregon
-$1K -500 Closed